Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors.
暂无分享,去创建一个
F. Blei | N. Key | S. Arkin | M. Heisel | C. Kisker | F. Shafer | G. Gilchrist | R. Foulke | J. Fetten | P. Shah | D. Strickland | C. Kitchen